Abstract: A method of treating or preventing vascular calcification in a patient by administering L-ascorbic acid or ascorbate to the patient and a pharmaceutical composition containing at least one statin and L-ascorbic acid or ascorbate in a dosage form that allows for the concomitant administering of the at least one statin and L-ascorbic acid or ascorbate to a patient.

Abstract: An example apparatus includes: An amplifier comprising folded cascode circuitry having an input and an output, an input pair coupled to the input, clamp circuitry including: a first transistor having a first drain, a first source, and a first gate, the first source coupled to the output, a second transistor having a second drain, a second source, and a second gate, the second drain coupled to the first drain and the second gate coupled to the first drain and second drain, a third transistor having a third drain, a third source, and a third gate, the third source coupled to the output, and a fourth transistor having a fourth drain, a fourth source, and a fourth gate, the fourth drain coupled to the third drain and the fourth gate coupled to the third drain and the fourth drain.

Abstract: A method of treating or preventing vascular calcification in a patient by administering L-ascorbic acid or ascorbate to the patient and a pharmaceutical composition containing at least one statin and L-ascorbic acid or ascorbate in a dosage form that allows for the concomitant administering of the at least one statin and L-ascorbic acid or ascorbate to a patient.

Abstract: A method of treating or preventing vascular calcification in a patient by administering L-ascorbic acid or ascorbate to the patient and a pharmaceutical composition containing at least one statin and L-ascorbic acid or ascorbate in a dosage form that allows for the concomitant administering of the at least one statin and L-ascorbic acid or ascorbate to a patient.

Abstract: A method of treating or preventing vascular calcification in a patient by administering L-ascorbic acid or ascorbate to the patient and a pharmaceutical composition containing at least one statin and L-ascorbic acid or ascorbate in a dosage form that allows for the concomitant administering of the at least one statin and L-ascorbic acid or ascorbate to a patient.

Abstract: A method of treating or preventing vascular calcification in a patient by administering L-ascorbic acid or ascorbate to the patient and a pharmaceutical composition containing at least one statin and L-ascorbic acid or ascorbate in a dosage form that allows for the concomitant administering of the at least one statin and L-ascorbic acid or ascorbate to a patient.

Abstract: A host includes persistent storage and a communication manager. The persistent storage stores an address conversion table. The communication manager obtains a multi-agent initiation request from an application. The communication manager also generates a network communication based on the multi-agent initiation request using the address conversion table. The communication manager also transmits the network communication to at least two other hosts.

Abstract: A method of treating or preventing vascular calcification in a patient by administering L-ascorbic acid or ascorbate to the patient and a pharmaceutical composition containing at least one statin and L-ascorbic acid or ascorbate in a dosage form that allows for the concomitant administering of the at least one statin and L-ascorbic acid or ascorbate to a patient.

Abstract: A host includes persistent storage and a communication manager. The persistent storage stores an address conversion table. The communication manager obtains a multi-agent initiation request from an application. The communication manager also generates a network communication based on the multi-agent initiation request using the address conversion table. The communication manager also transmits the network communication to at least two other hosts.

Abstract: An access point information handling system (IHS) group management system includes a group management IHS that is coupled to a plurality of access point IHSs through a network. The group management IHS receives a group request from a first access point IHS, then retrieves group configuration information from the group configuration database using information about the first access point IHS, and uses the group configuration information to determine an access point IHS group. The access point IHS group includes the first access point IHS and at least one second access point IHS. The group management IHS then determines an access point IHS group controller that is one of the first access point IHS and the at least one second access point IHS. The group management IHS then identifies the access point IHS group and the access point IHS group controller to the first access point IHS.

Abstract: An access point information handling system (IHS) group management system includes a group management IHS that is coupled to a plurality of access point IHSs through a network. The group management IHS receives a group request from a first access point IHS, then retrieves group configuration information from the group configuration database using information about the first access point IHS, and uses the group configuration information to determine an access point IHS group. The access point IHS group includes the first access point IHS and at least one second access point IHS. The group management IHS then determines an access point IHS group controller that is one of the first access point IHS and the at least one second access point IHS. The group management IHS then identifies the access point IHS group and the access point IHS group controller to the first access point IHS.

Abstract: Offset calibration technique to improve performance of band gap voltage reference. An example of a bandgap reference source includes an output resistor, a first and second transistors and a differential amplifier. A positive-input calibration phase switch is in communication with a positive amplifier input, a emitter of the first and second transistor and a negative-input calibration phase switch in communication with the negative amplifier input, the emitter of the first and second transistor. A positive-output calibration phase switch is in communication with the positive amplifier output, the first and second terminal of the output resistor and a negative-output calibration phase switch is in communication with the negative amplifier output, the first and second terminal of the output resistor. An adjustable resistance is in communication with the emitter of the first transistor, the emitter of the second transistor, and the second terminal of the output resistor.

Abstract: The technology performs predictive analytics on web content for users researching or tracking detailed topics on the web who are limited by the sparse input capability of current search tools. Using a machine learning technology core and other predictive analytics tools, the technology allows users to create predictive models based on exemplars of their interest such as articles and documents. Predictive models are mathematically patterned and pointed at the web. Results are presented to the user, with the ability to re-train the system as desired as well as create new models. This particular invention has the ability to connect users with similar interests by comparing their predictive models, thus facilitating collaboration and promoting social media interaction (“social clustering”).

Abstract: The invention performs predictive analytics on web content for users researching or tracking detailed topics on the web who are limited by the sparse input capability of current search tools. Using a machine learning technology core and other predictive analytics tools, the invention allows users to create predictive models based on exemplars of their interest such as articles and documents. Predictive models are mathematically patterned and pointed at the web. Results are presented to the user, with the ability to re-train the system as desired as well as create new models.

Abstract: Offset calibration technique to improve performance of band gap voltage reference. An example of a bandgap reference source includes an output resistor, a first and second transistors and a differential amplifier. A positive-input calibration phase switch is in communication with a positive amplifier input, a emitter of the first and second transistor and a negative-input calibration phase switch in communication with the negative amplifier input, the emitter of the first and second transistor. A positive-output calibration phase switch is in communication with the positive amplifier output, the first and second terminal of the output resistor and a negative-output calibration phase switch is in communication with the negative amplifier output, the first and second terminal of the output resistor. An adjustable resistance is in communication with the emitter of the first transistor, the emitter of the second transistor, and the second terminal of the output resistor.

Abstract: The invention relates to an electronic device which comprises a comparator coupled to monitor a first supply voltage level at a first supply voltage node. The comparator comprises a differential input transistor stage having one input coupled to the first supply voltage node and the other input coupled to receive a reference voltage level, a first current source configured to supply a current of a first magnitude, a second current source configured to supply a current of a second magnitude, and a capacitor. The first magnitude is greater than the second magnitude and the first current source is coupled with one side to the differential input stage for supplying the differential input stage and with the other side to a first node. The second current source is coupled with one side to the first node and with the other side to a second supply voltage node having a second supply voltage level and the capacitor is coupled with one side to the first node and with the other side to the first supply voltage node.

Abstract: The present invention relates to compositions and methods relating to prophylactic treatment and treatment of meconium aspiration syndrome comprising administering to a subject in need of treatment a therapeutically effective amount of acetylcysteine (N-acetyl-L-cysteine). One aspect of the invention relates to pharmaceutical compositions and methods of treatment comprising acetylcysteine and/or DNAse and/or a compound of the antiprotease family of drugs, administered singly or in combination, as medicament for treatment of meconium aspiration syndrome admixed with a pharmaceutically acceptable diluent, carrier, or excipient.

Abstract: The present invention provides biochemical compositions effective in inhibiting an atherogenic process, comprising ascorbic acid, lysine, magnesium, cysteine, pyridoxine HCL, riboflavin, folic acid, cyanocobalamin vitamin B12, S-Adenosyl-L-Methionine (SAMe), choline bitartrate, copper glycinate, epigallocatechin gallate, quercetin, asiatic acid, and pycnogenol.

Abstract: A composition comprising of polyphenols, an ascorbic compound, lysine, and proline, have been found to retard viral activity. As such, methods of treating viral infection, and methods of retarding viral activity are provided herein.

Abstract: The present invention provides pharmaceutical compositions comprising lysine, proline, arginine, vitamin C, magnesium, green tea extract, N-acetylcysteine, selenium, copper, manganese and one pharmaceutical acceptable component selected from the group consisting of a carrier, a diluent, and an excipient, wherein the pharmaceutical composition without the acceptable component contains 7-9 wt % magnesium, 20-30 wt % ascorbic acid and 11-25 wt % green tea extract A method of treting cardio-vascular diseases using the pharmaceutical compositions are also disclosed, more preferably for the treatment of post-menopausal women.